Drug Shortage Report for TRAJENTA

Last updated on 2017-12-22 History
Report ID 28642
Drug Identification Number 02370921
Brand name TRAJENTA
Common or Proper name Trajenta
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status MARKETED
Active Ingredient(s) LINAGLIPTIN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90's
ATC code A10BH
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-11-10
Actual start date 2017-11-14
Estimated end date 2017-11-21
Actual end date 2017-12-21
Shortage status Resolved
Updated date 2017-12-22
Company comments TRAJENTA 5MG TABLETS 3 X 10 REMAINS AVAILABLE
Health Canada comments
Tier 3 Status No
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2017-12-22 French Compare
v9 2017-12-08 French Compare
v8 2017-12-08 English Compare
v7 2017-11-28 French Compare
v6 2017-11-28 English Compare
v5 2017-11-11 English Compare
v4 2017-11-09 French Compare
v3 2017-11-09 English Compare
v2 2017-11-08 French Compare
v1 2017-11-08 English Compare

Showing 1 to 10 of 10